These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 608198)

  • 41. Microbial contamination potential of solutions in prefilled disposable syringes used with a syringe pump.
    Mitrano FP; Baptista RJ; Newton DW; Augustine SC
    Am J Hosp Pharm; 1986 Jan; 43(1):78-80. PubMed ID: 3953587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Contribution of paramedical personnel to the activities of the microbiological control and study of pharmaceuticals].
    Lungu G; Dumitrescu A; Iordan F; Cisa V
    Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit; 1983 Sep; 31(9):205-8. PubMed ID: 6417901
    [No Abstract]   [Full Text] [Related]  

  • 43. [Problems on radionuclidic impurities in the use and measurements of radioisotopes].
    Kawada Y
    Radioisotopes; 1983 Feb; 32(2):81-90. PubMed ID: 6346406
    [No Abstract]   [Full Text] [Related]  

  • 44. Silting index determination--an alternative to particle counting for the control of particulate contamination in infusion fluids.
    Ernerot L
    Acta Pharm Suec; 1974 Feb; 11(1):15-24. PubMed ID: 4816412
    [No Abstract]   [Full Text] [Related]  

  • 45. Particulate inspection of parenteral products: an assessment.
    Knapp JZ; Kushner HK; Abramson LR
    J Parenter Sci Technol; 1981; 35(4):176-85. PubMed ID: 7277132
    [No Abstract]   [Full Text] [Related]  

  • 46. Particulate contamination in New Zealand intravenous solutions.
    Passl WJ; Waring JM
    N Z Med J; 1980 Mar; 91(655):177-9. PubMed ID: 6929987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and validation of HPLC method for the determination of Cyclosporin A and its impurities in Neoral capsules and its generic versions.
    Bonifacio FN; Giocanti M; Reynier JP; Lacarelle B; Nicolay A
    J Pharm Biomed Anal; 2009 Feb; 49(2):540-6. PubMed ID: 19124213
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Problems of control of polymers used in drug technology].
    Krówczyński L
    Polim Med; 1984; 14(1-4):5-12. PubMed ID: 6533635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Study concept of traditional Chinese medicine quality standards].
    Chen J; Chen L; An Z; Chang Z; Yuan X; Zhan Y
    Zhong Yao Cai; 2002 Oct; 25(10):748-50. PubMed ID: 15562726
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Possibilities of material contamination due to additional injections].
    Mehrkens HH; Klaus E; Schmitz JE
    Klin Anasthesiol Intensivther; 1977; (14):106-13. PubMed ID: 926676
    [No Abstract]   [Full Text] [Related]  

  • 51. [Possibilities of material contamination due to additional injections].
    Müller-Stock A
    Klin Anasthesiol Intensivther; 1977; (14):114-20. PubMed ID: 926677
    [No Abstract]   [Full Text] [Related]  

  • 52. [Ensuring the sterility of infusion solutions].
    Meyer KH; Bickel H
    Klin Anasthesiol Intensivther; 1977; (14):18-20. PubMed ID: 926685
    [No Abstract]   [Full Text] [Related]  

  • 53. Quantitative determination of chemicals leached from rubber stoppers into parenteral solutions.
    Danielson JW; Oxborrow GS; Placencia AM
    J Parenter Sci Technol; 1984; 38(3):90-3. PubMed ID: 6747780
    [No Abstract]   [Full Text] [Related]  

  • 54. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design control and validation of a facility for sterile clinical trial preparations.
    Staines L
    J Parenter Sci Technol; 1984; 38(3):109-14. PubMed ID: 6747778
    [No Abstract]   [Full Text] [Related]  

  • 56. The regulation of medicinal products derived from human blood or plasma in the European Community.
    Brunko P
    Dev Biol Stand; 1993; 81():269-71. PubMed ID: 8174813
    [No Abstract]   [Full Text] [Related]  

  • 57. Re: the fourteen-day sterility test: how we got there.
    Olson WP
    PDA J Pharm Sci Technol; 1996; 50(4):198. PubMed ID: 8810830
    [No Abstract]   [Full Text] [Related]  

  • 58. A study of particulate matter in I.V. infusion fluids.
    Davis NM; Turco S; Sivelly E
    Am J Hosp Pharm; 1970 Oct; 27(10):822-6. PubMed ID: 5473472
    [No Abstract]   [Full Text] [Related]  

  • 59. [Filter systems for the prevention of material and bacterial contamination].
    Ahnefeld FW; Dick W
    Klin Anasthesiol Intensivther; 1977; (14):131-8. PubMed ID: 926679
    [No Abstract]   [Full Text] [Related]  

  • 60. [Study of insoluble contaminants in large-volume parental infusion fluids, II. Evaluation of the degree of contamination with insoluble particles of parenteral infusion fluids produced by the pharmaceutical industry and hospital pharmacies].
    Pawlaczyk J; Nowacka D; Wawrzyńczak D
    Acta Pol Pharm; 1982; 39(1-3):151-7. PubMed ID: 7180545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.